MASS — 908 Devices Inc
NASDAQ · Healthcare · Medical Devices
$10.71
+$0.06 (+0.56%)
908 Devices Inc (MASS) is a medical devices company listed on NASDAQ. It is led by Kevin J. Knopp Ph.D., based in 645 Summer Street, Boston, MA, United States, 02210, with about 246 employees. 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company's products comprise Maven, an on-line device for bioprocess monitoring and control; Trace C2, an on-line monitoring of methanol or ethanol and control of substrate feeding in fermentation processes; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Latest reported MASS revenue for 2025-09-30 was $14.0M. Net income was $15.3M. Revenue was up 7.4% from 2025-06-30 to 2025-09-30. MASS currently screens at market cap $238.5M.
Use this MASS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MASS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MASS SEC filings page. Lician reads the product cache first so this HTML stays unique to 908 Devices Inc even when a live quote feed is slow.
About 908 Devices Inc
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company's products comprise Maven, an on-line device for bioprocess monitoring and control; Trace C2, an on-line monitoring of methanol or ethanol and control of substrate feeding in fermentation processes; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
MASS Key Statistics
Market Cap
$238.48M
Volume
273,064
Previous Close
$10.92
Day Range
$10.56 – $11.04
EPS
-$2.12
Revenue
$59.63M
Net Income
-$72.21M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+18.7%
Profit Margin
-121.1%
Employees
246
MASS Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $59.63M | $50.23M | $46.85M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$72.21M | -$36.40M | -$33.56M |
| EPS (Diluted) | -$2.12 | -$1.13 | -$1.07 |
Total Assets
$159.48M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$44.03M
Operating Cash Flow
-$30.25M
Free Cash Flow
$0.00
908 Devices Inc Company Information
- Co-Founder, CEO, President & Director
- Kevin J. Knopp Ph.D.
- Headquarters
- 645 Summer Street, Boston, MA, United States, 02210
- Website
- 908devices.com
- Phone
- 857 254 1500
- IPO / Founded
- 2020-12-18
- Sector
- Healthcare
- Industry
- Medical Devices